Short-term glutamine supplementation decreases lung inflammation and the receptor for advanced glycation end-products expression in direct acute lung injury in mice

BACKGROUND: Glutamine (GLN) has been reported to improve clinical and experimental sepsis outcomes. However, the mechanisms underlying the actions of GLN remain unclear, and may depend upon the route of GLN administration and the model of acute lung injury (ALI) used. The aim of this study was to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuang, Yin-Ching, Shaw, Huey-Mei, Chen, Chi-Chung, Pan, He-Jia, Lai, Wei-Chih, Huang, Hui-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109782/
https://www.ncbi.nlm.nih.gov/pubmed/25022445
http://dx.doi.org/10.1186/1471-2466-14-115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109782/
https://www.ncbi.nlm.nih.gov/pubmed/25022445
http://dx.doi.org/10.1186/1471-2466-14-115

Ejemplares similares